{"id":"W2887698070","doi":"10.1158/1538-7445.am2018-ct112","title":"Abstract CT112: Durvalumab + tremelimumab in patients with metastatic urothelial cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Durvalumab; Medicine; Tremelimumab; Discontinuation; Internal medicine; Refractory (planetary science); Blockade; Cancer; Gastroenterology; Chemotherapy; Response Evaluation Criteria in Solid Tumors; Cohort; Oncology; Phases of clinical research; Immunotherapy; Pembrolizumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003719472,0.0002203785,0.0004915042,0.0001061389,0.0001678378,0.0002844393,0.0001962356,0.0002093369,0.002165784],"category_scores_gemma":[0.0005969015,0.00008243865,0.0002435566,0.0002095584,0.0001065122,0.0002221983,0.000173864,0.0003679114,0.0003331075],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005338984,"about_ca_system_score_gemma":0.0004478536,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007429775,"about_ca_topic_score_gemma":0.001887715,"domain_scores_codex":[0.9998713,0.00004495311,0.00001357198,0.00002843459,0.00002160843,0.00002015413],"domain_scores_gemma":[0.9998159,0.0000324758,0.00004490079,0.000007641295,0.00001221305,0.00008694323],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.1781359,0.002768547,0.3679781,0.001206153,0.001066077,0.002473348,0.0002043949,0.002795615,0.048676,0.0002672214,0.01717913,0.3772495],"study_design_scores_gemma":[0.03567562,0.1251476,0.7854838,0.0002198595,0.001063422,0.006678241,0.0001576565,0.005507311,0.01252411,0.0003171297,0.02718812,0.00003713367],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"other","genre_scores_codex":[0.9920322,0.003794475,0.000180033,0.0004099434,0.00004155412,0.000104074,0.0006921571,0.00003094765,0.002714744],"genre_scores_gemma":[0.9977074,0.0004989731,0.0002618795,0.0001623131,0.00004777086,0.00004601814,0.0006765287,0.000003572964,0.000595473],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.002165784,"threshold_uncertainty_score":0.007245302,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07978595004423476,"score_gpt":0.4120203206080332,"score_spread":0.3322343705637985,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}